I’ve wondered why Warren Buffett didn’t own Apple (AAPL), since it epitomizes the type of stock he likes. It pays a solid dividend (2.5%), generates enormous cash flow, and is priced at a discount to the overall stock market based on its forward P/E multiple. That’s also why I own… Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
Toward the end of a long and productive life, my late father-in-law came to live with my wife and me when he could no longer look out for himself. For a nonagenarian he was remarkably lucid and able to recall the details of his life many decades ago. So I… Read More
Next week the entire Investing Daily team of analysts is headed to Las Vegas for our Wealth Society Investing Summit 2016 to discuss the current state of the financial markets with dozens of our subscribers. The social highlight of the event will be a presentation by ID’s Editorial Director… Read More
One of the exoskeleton stocks I discussed in this week’s issue of Breakthrough Tech Weekly, Ekso Bionics (EKSO), announced a 1:7 reverse stock split effective immediately so it can begin trading on the more liquid NASDAQ Capital Market exchange. This transaction will have the effect of increasing Ekso’s share… Read More
As we discussed in this week’s issue of Breakthrough Tech Weekly, exoskeleton manufacturer ReWalk Robotics (RWLK) released first quarter earnings yesterday that were in line with expectations. The company reported a quarterly loss of $6.9 million, or 56 cents per share (48 cents adjusted for option expense and… Read More
Last August, in an article I wrote for Smart Tech Investor (now Breakthrough Tech Profits), I posited, “Is Icahn Selling Apple?” I figured that Icahn needed to raise cash to cover huge losses in his energy portfolio. I also questioned how much longer he and Apple CEO Tim… Read More
We hate to say we told you so, but ... Read More
After yesterday’s stock market close Argos Therapeutics (ARGS) announced that its Chief Operating Officer will resign effective this Friday, and it will lay off 18 employees to stay within budget. This morning the stock is down nearly $3 (27%) on the news, presumably the result of rattled shareholders dumping stock… Read More
You’ve made a great decision to join me and my team for a year of explosive profits from traditional technology companies as well as companies which leverage technology to solve some of the world’s biggest challenges.One such example is Argos Therapeutics which is already up 179% since we first recommended… Read More
To make room for the new recommendations we will be adding to the Breakthrough Tech Stocks portfolio we are revising the STI portfolios, Read More